Serum lipid profiles among patients initiating ritonavir-boosted atazanavir versus efavirenz-based regimens

BACKGROUND: Antiretrovirals used to treat HIV-infected patients have the potential to adversely affect serum lipid profiles and increase the risk of cardiovascular disease which is an emerging concern among HIV-infected patients. Since boosted atazanavir and efavirenz are both considered preferred a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Ganesan, Anuradha, Benning, Lorie, Golub, Elizabeth T, Riddle, Mark, Crum-Cianflone, Nancy, Tasker, Sybil, Jacobson, Lisa, Gange, Stephen J
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2009
Teme:
Short Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2712469/
https://ncbi.nlm.nih.gov/pubmed/19545433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1742-6405-6-13
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki